research
Recent Rosacea Blog Posts
News today that Glenmark Pharmaceutiacals has received approval from the FDA to manufacture a generic form of Azelaic Acid Gel 15% (marketed under the name Finacea). There has been quite a bit of business activity related to Finacea in the last year. Indeed back in 2013 we learnt that Bayer HealthCare the makers of Finacea, […]
A recent ruling from a Delaware Federal judge has confirmed that Galderma’s patent protection covering Oracea is secure, and confirming that generic Oracea is just not going to happen. This most recent ruling found that Amneal Pharmaceuticals’s attempt to create a generic version of the once-daily low dose doxycycline treatment infringes 5 of Galderma’s US […]
Rosacea sufferers are suffocating under a pile of research that suggests we are at higher risk of an ever growing list of diseases. This time rosacea sufferers are being told that they have a higher risk of cardiovascular disease compared to non-rosacea sufferers. Here’s what you need to know. Firstly, this research appears to fit […]
This paper, a sponsored supplement in the DermatologyTimes is detailing the latest and greatest treatments for rosacea. Drs. Baldwin, Bhatia, Del Rosso, Stein-Gold, and Webster are asked a series of questions relating to their clinical experience in treating rosacea. Best Practices in the Treatment of Rosacea In this Dermatology Times supplement, a group of experts in […]
This just published article is describing some clinical work has been concluded that proposes using topical Ivermectin (Soolantra) to treat ocular rosacea. Soolantra so far has only been approved as a treatment for the papules and pustules of rosacea. Soolantra is thought to be effective against rosacea because of its anti-demodex and anti-inflammatory properties. […]
